The reason may be that pregnant women infected with HBV in our study were treated with LAM or TDF right from the 28th week of pregnancy, so the rate of detection of HBsAg in breast milk may be affected by antiviral drugs, while other studies were conducted on women who did not interfere with antiviral treatment.